Literature DB >> 23281933

Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor.

Alexandra Vetter1, Kulpreet S Virdi, Sigrid Espenlaub, Wolfgang Rödl, Ernst Wagner, Per S Holm, Christina Scheu, Florian Kreppel, Christine Spitzweg, Manfred Ogris.   

Abstract

Adenovirus type 5 (Ad) is an efficient gene vector with high gene transduction potential, but its efficiency depends on its native cell receptors coxsackie- and adenovirus receptor (CAR) for cell attachment and α(v)β(3/5) integrins for internalization. To enable transduction of CAR negative cancer cell lines, we have coated the negatively charged Ad by noncovalent charge interaction with cationic PAMAM (polyamidoamine) dendrimers. The specificity for tumor cell infection was increased by targeting the coated Ad to the epidermal growth factor receptor using the peptide ligand GE11, which was coupled to the PAMAM dendrimer via a 2 kDa PEG spacer. Particles were examined by measuring surface charge and size, the degree of coating was determined by transmission electron microscopy. The net positive charge of PAMAM coated Ad enhanced cellular binding and uptake leading to increased transduction efficiency, especially in low to medium CAR expressing cancer cell lines using enhanced green fluorescent protein or luciferase as transgene. While PAMAM coated Ad allowed for efficient internalization, coating with linear polyethylenimine induced excessive particle aggregation, elevated cellular toxicity and lowered transduction efficiency. PAMAM coating of Ad enabled successful transduction of cells in vitro even in the presence of neutralizing antibodies. Taken together, this study clearly proves noncovalent, charge-based coating of Ad vectors with ligand-equipped dendrimers as a viable strategy for efficient transduction of cells otherwise refractory to Ad infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23281933     DOI: 10.1021/mp300366f

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  15 in total

1.  pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.

Authors:  Joung-Woo Choi; Soo-Jung Jung; Dayananda Kasala; June Kyu Hwang; Jun Hu; You Han Bae; Chae-Ok Yun
Journal:  J Control Release       Date:  2015-01-07       Impact factor: 9.776

Review 2.  Oncolytic viruses: adenoviruses.

Authors:  Julia Niemann; Florian Kühnel
Journal:  Virus Genes       Date:  2017-07-12       Impact factor: 2.198

Review 3.  Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.

Authors:  Seren Marsh; Britt Hanson; Matthew J A Wood; Miguel A Varela; Thomas C Roberts
Journal:  Mol Ther       Date:  2020-10-14       Impact factor: 11.454

Review 4.  Synthetic virology: engineering viruses for gene delivery.

Authors:  Caitlin M Guenther; Brianna E Kuypers; Michael T Lam; Tawana M Robinson; Julia Zhao; Junghae Suh
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-09-04

Review 5.  Retargeting adenoviruses for therapeutic applications and vaccines.

Authors:  Michael A Barry; Jeffrey D Rubin; Shao-Chia Lu
Journal:  FEBS Lett       Date:  2020-02-03       Impact factor: 4.124

6.  Polymer-enhanced delivery increases adenoviral gene expression in an orthotopic model of bladder cancer.

Authors:  Helen Gosnell; Laura M Kasman; Thrimoorthy Potta; Lucas Vu; Elizabeth Garrett-Mayer; Kaushal Rege; Christina Voelkel-Johnson
Journal:  J Control Release       Date:  2013-12-24       Impact factor: 9.776

Review 7.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

8.  Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.

Authors:  A Moretti; L Fonteyne; F Giesert; P Hoppmann; A B Meier; T Bozoglu; A Baehr; C M Schneider; D Sinnecker; K Klett; T Fröhlich; F Abdel Rahman; T Haufe; S Sun; V Jurisch; B Kessler; R Hinkel; R Dirschinger; E Martens; C Jilek; A Graf; S Krebs; G Santamaria; M Kurome; V Zakhartchenko; B Campbell; K Voelse; A Wolf; T Ziegler; S Reichert; S Lee; F Flenkenthaler; T Dorn; I Jeremias; H Blum; A Dendorfer; A Schnieke; S Krause; M C Walter; N Klymiuk; K L Laugwitz; E Wolf; W Wurst; C Kupatt
Journal:  Nat Med       Date:  2020-01-27       Impact factor: 53.440

Review 9.  The evolution of adenoviral vectors through genetic and chemical surface modifications.

Authors:  Cristian Capasso; Mariangela Garofalo; Mari Hirvinen; Vincenzo Cerullo
Journal:  Viruses       Date:  2014-02-17       Impact factor: 5.048

10.  Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo.

Authors:  Jan-Michael Prill; Vladimír Subr; Noemi Pasquarelli; Tatjana Engler; Andrea Hoffmeister; Stefan Kochanek; Karel Ulbrich; Florian Kreppel
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.